Kidney Transplantation Clinical Trials

Phoenix : Mayo Clinic

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

San Francisco : UCSF Immune Tolerance Network

Study of Kidney Transplant Recipients and Their Donors

View More »

Los Angeles : St. Vincents Medical Center

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Los Angeles : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Los Angeles : Cedars-Sinai medical center

Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

Palo Alto : Stanford School of Medicine

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Palo Alto : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

San Diego : Pfizer Investigational Site Updated

Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient

San Diego : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

San Francisco : California Pacific Medical Center

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

San Francisco : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

San Francisco : University of California, San Francisco

NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients

Aurora : University of Colorado

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Aurora : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Gainesville : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Tampa : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Atlanta : Emory Healthcare - Emory University Hospital (EUH)

Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant

Chicago : University of Illinois

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Chicago : Pfizer Investigational Site Updated

Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient

Chicago : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Lexington : University of Kentucky Chandler Medical Center

Attention Kidney Transplant Patients

Ann Arbor : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Detroit : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Flint : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

St. Louis : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Bronx : Montefiore Medical Center

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Buffalo : Erie County Medical Center

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

New York : Pfizer Investigational Site Updated

Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient

Chapel Hill : University of North Carolina

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Chapel Hill : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Durham : Duke University Medical Center

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Harrisburg : Pinnacle Health at Harrisburg

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Philadelphia : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Charleston : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Charleston : The Medical University of South Carolina

Sirolimus Conversions in African-American Renal Transplant Recipients

Dallas : Baylor University Medical Center

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Dallas : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Fort Worth : Baylor All Saints Medical Center

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Fort Worth : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Houston : The Methodist Hospital

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

View More »

Houston : The Methodist Hospital Research Institute

Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation

Charlottesville : University of Virginia

A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Adelaide : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Camperdown : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Orange : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Parkville : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Westmead : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

View More »

Woodville : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Innsbruck : 1141

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Linz : 1142

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Vienna : 1140

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Vienna : Vienna General Hospital (AKH)/11

A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Vienna :

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Minsk : 3240

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Anderlecht : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Brussels :

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Ghent : University Hospital Ghent

Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study

Leuven : K.U.Leuven/22

A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Porto Alegre : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Sao Paulo : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Calgary : Foothills Medical Centre

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Edmonton : University of Alberta Hospital

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Edmonton : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Halifax : Capital District Health Authority

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Hamilton : St. Joseph's Healthcare

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

View More »

London : London Health Sciences Centre

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Montreal : Hôpital Notre-Dame du CHUM

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Montreal : McGill University Health Centre

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Montreal : Hôpital Maisonneuve-Rosemont

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Quebec : Centre Hospitalier Universitaire de Québec

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Saskatoon : St. Paul's Hospital

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Saskatoon : St Paul's Hospital

Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk

Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke (CHUS)-Hopital Fleurimont

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Toronto : St. Michael's Hospital

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Winnipeg : Health Sciences Centre

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Beijing : The 309th Hospital of Chinese People's Liberation Army

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Beijing : Chinese PLA General Hospital

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Beijing : Peking University First Hospital

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Beijing : Beijing Friendship Hospital

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Beijing : Beijing Chaoyang Hospital

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

View More »

Changsha : The Second Xiangya Hospital of Central South University

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Chengdu : West China Hospital,Sichuan University

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Fuzhou : Fuzhou General Hospital of Nanjing Military Command

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Guangzhou : The First affiliated Hospital Sun Yat-sen University

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Guangzhou : Nanfang Hospital

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Hangzhou : The First Affiliated Hospital, Zhejiang University

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Jinan : Jinan Military General Hospital

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Shanghai : Zhongshan Hospital Fudan University

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Shanghai : Shanghai First People's Hospital

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Shenyang : Shenyang Military General Hospital

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Wuhan : Tongji Hospital

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Xian : First Affiliated Hospital of Medical College of Xian Jiaotong University

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Zhengzhou : The First Affiliated Hospital of Zhengzhou University

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China

Brno : Site 1441

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Ostrava - Poruba : 1440

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Prague : University Hospital Motol/61

A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Praha 4 : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Aarhus N : Dept. of Renal Medicine, Aarhus University Hospital, Skejby

Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function

Amiens Cedex : 1752

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Brest Cedex 2 : 1740

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Bron :

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Clermont-Ferrand Cedex 1 : 1742

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Creteil Cedex : 1746

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

View More »

Dijon : 1750

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Le Kremilin Bicetre Cedex : 1741

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Paris :

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Paris Cedex 15 : 1749

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Paris Cedex 15 : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Toulouse Cedex 9 : 1751

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Tours cedex 9 : 1748

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Vandoeuvre Les Nancy : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Vandoeuvre Les Nancy Cedex : 1745

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Berlin : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Berlin : Universitätsklinikum Charité

Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen

Bochum : 1541

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Erlangen : 1542

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Essen : 1543

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

View More »

Frankfurt : 1544

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Giessen : Department of Internal Medicine, University of Giessen

Impact of Rituximab Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Hann.Munden : 1545

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Heidelberg : Site 30

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

Heidelberg : 1546

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Heidelberg : Site 30

A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Heidelberg :

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Kiel : 1547

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Leipzig : 1548

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Munchen : 1549

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Munster : 1550

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Budapest : 1941

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Budapest :

ORANGE Study: An Observational Study on Renal Function in Kidney Transplant Patients on Immunosuppressive Therapy Containing CellCept (Mycophenolate Mofetil)

Pecs :

ORANGE Study: An Observational Study on Renal Function in Kidney Transplant Patients on Immunosuppressive Therapy Containing CellCept (Mycophenolate Mofetil)

Ancona : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Bergamo : Ospedali Riuniti di Bergamo/51

A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Bologna : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Bologna : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Brescia : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

View More »

Cagliari : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Coppito : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Firenze : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Milano : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Modena : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Novara : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Padova : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Palermo : 2144

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Palermo : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Pavia : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Reggio Calabria : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Roma : 2143

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Roma : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Salerno : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Siena : 2140

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Siena : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Verona : Novartis Investigative Site

Everolimus in de Novo Kidney Transplant Recipients

Tokyo : Novartis Pharmaceuticals, Japan

Concentration Controlled Everolimus With Reduced Dose Neoral® Versus Mycophenolate Mofetil With Standard Dose Neoral® in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids

Seoul : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Cheras : Hospital Universiti Kebangsaan Malaysia

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

Kota Bharu : Hospital Raja Perempuan Zainab II

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

Kota Kinabalu : Hospital Queen Elizabeth

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

Kuala Lumpur : Hospital Kuala Lumpur

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

Kuantan : Hospital Tengku Ampuan Afzan

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

View More »

Kuching : Hospital Umum Sarawak

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

Pulau Pinang : Hospital Pulau Pinang

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

Selayang : Hospital Selayang

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

Serdang : Hospital Serdang

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms

Maastricht : 2240

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Oslo : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Bydgoszcz : Klinika Transplantologii, Szpital Uniwersytecki, ul. M. Sklodowskiej-Curie 9

Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation

Lodz : 2640

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Poznan : 2641

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Warsaw : Site 50

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

Warsaw : Children's Memorial Health Institute/71

A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

View More »

Warsaw : Children's Memorial Health Institute/72

A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Warsaw : Site 50

A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Warsaw :

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Wroclaw : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Kemerovo : 2841

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Moscow : 2843

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Omsk : 2842

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Vol'ginskiy : 2840

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Alicante : 1640

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Barcelona : 1641

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Barcelona : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Hospitalet de Llobregat : Pfizer Investigational Site Updated

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Madrid : Site 21

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

View More »

Madrid : Site 22

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

Madrid : Site 22

A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Madrid : Site 21

A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Santander : 1643

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Vizcaya : 1642

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Gothenburg : Sahlgrenska Transplant Institute, Sahlgrenska Academy at the University of Gothenborg

Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function

Birmingham : University Hospital Birmingham

Study of Rituximab to Treat Chronic Renal Transplant Rejection

Birmingham :

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Cardiff : Univeristy Hospital of Wales

Study of Rituximab to Treat Chronic Renal Transplant Rejection

Hull : Hull Royal Infirmary

Study of Rituximab to Treat Chronic Renal Transplant Rejection

Leeds : St Jame's University Hospital

Study of Rituximab to Treat Chronic Renal Transplant Rejection

View More »

London : King's College London, Guy's Hospital

Study of Rituximab to Treat Chronic Renal Transplant Rejection

London : Imperial College London and West London Renal & Transplantation Centre

Study of Rituximab to Treat Chronic Renal Transplant Rejection

London : The Royal Free Hospital

Study of Rituximab to Treat Chronic Renal Transplant Rejection

Manchester : Site 13

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

Manchester : Royal Manchester Children's Hospital/42

A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Manchester : Site 13

A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Manchester : Manchester Royal Infirmary

Study of Rituximab to Treat Chronic Renal Transplant Rejection

Manchester :

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®